Prescribing Guides
Ceftriaxone Prescribing Guide for Indian Clinical Practice
Complete ceftriaxone prescribing reference for Indian clinicians covering indications, dosing, reconstitution, drug interactions and NEET PG points.
MedNext Editorial Team | 2026-08-01 | 8 min read
Ceftriaxone Prescribing Guide for Indian Clinical Practice
Complete ceftriaxone prescribing reference for Indian clinicians covering indications, dosing, reconstitution, drug interactions and NEET PG points.
Ceftriaxone is a third-generation cephalosporin and one of the most commonly used injectable antibiotics in Indian hospitals. Its long half-life allows once-daily dosing and its broad spectrum covers many gram-negative and gram-positive organisms.
Clinical Pharmacology Overview
Ceftriaxone is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). It has excellent activity against Enterobacteriaceae, Neisseria, Haemophilus, and Streptococci. It has limited activity against Pseudomonas aeruginosa (unlike ceftazidime) and no activity against MRSA or Enterococci.
Pharmacokinetics: Bioavailability is 100% by IM or IV route (not absorbed orally). Protein binding is 85-95%. It has dual elimination -- approximately 60% renal and 40% biliary, making it unique among cephalosporins. Half-life is 6-9 hours, the longest among cephalosporins, allowing once-daily dosing. It achieves good CSF penetration in inflamed meninges.
Indian Brand Names
- Monocef (Aristo Pharmaceuticals)
- Oframax (Sun Pharma)
- Monotax (Zydus Cadila)
- Xone (Alkem Laboratories)
- Cefaxone (Lupin)
Approved Indications in Indian Clinical Practice
- Community-acquired pneumonia
- Bacterial meningitis (empirical and directed therapy)
- Intra-abdominal infections (usually with metronidazole)
- Urinary tract infections (complicated)
- Gonorrhoea (single-dose therapy)
- Septicaemia and bacteraemia
- Surgical prophylaxis (single pre-operative dose)
- Enteric fever (typhoid) -- widely used in India
- Acute otitis media (when oral therapy fails)
Dosing in Adults
Standard dose: 1-2 g IV or IM once daily.
Meningitis: 2 g IV every 12 hours.
Gonorrhoea: 250 mg IM as a single dose (combined with azithromycin 1 g orally).
Enteric fever: 2 g IV once daily for 10-14 days in complicated cases.
Surgical prophylaxis: 1-2 g IV 30-60 minutes before incision.
IM injection: reconstitute with 1% lignocaine to reduce pain at the injection site.
Important Drug Interactions
- Calcium-containing IV solutions (Ringer lactate, calcium gluconate): formation of insoluble ceftriaxone-calcium precipitates -- NEVER co-administer through the same line
- Warfarin: may enhance anticoagulant effect by disrupting gut flora vitamin K synthesis
- Loop diuretics (furosemide): theoretical increased nephrotoxicity risk at high doses
- Probenecid: does not significantly affect ceftriaxone clearance (unlike other cephalosporins) due to biliary elimination
Side Effects and Monitoring
Common: diarrhoea, nausea, injection site pain, rash.
Serious: anaphylaxis (check for penicillin allergy -- approximately 1-2% cross-reactivity), Clostridioides difficile-associated diarrhoea, biliary sludge or pseudolithiasis (especially with prolonged high doses), haematological effects (leucopenia, thrombocytopenia, eosinophilia).
Monitoring: complete blood count and liver function tests for courses beyond 10 days. Watch for signs of biliary sludge (right upper quadrant pain, nausea) in prolonged therapy.
Special Populations
Pregnancy: Category B. Generally considered safe. Widely used in Indian obstetric practice for infections during pregnancy.
Renal impairment: No dose adjustment needed in isolated renal impairment due to biliary excretion. In combined hepatic and renal impairment, do not exceed 2 g per day.
Neonates: Use with caution. Displaces bilirubin from albumin -- contraindicated in hyperbilirubinaemic or premature neonates. Never co-administer with IV calcium in neonates.
Elderly: No specific dose adjustment but monitor for superinfection and C. difficile.
NEET PG High-Yield Points
- Longest half-life among cephalosporins (once-daily dosing)
- Dual elimination: renal + biliary (unique among cephalosporins)
- Good CSF penetration -- drug of choice for gram-negative meningitis
- Biliary sludge/pseudolithiasis is a characteristic adverse effect
- Calcium incompatibility -- fatal precipitates in neonates
- Does NOT cover Pseudomonas (use ceftazidime or cefepime)
- Does NOT cover MRSA or Enterococci
- Third-generation cephalosporins are associated with ESBL induction
Indian Regulatory Status
Ceftriaxone is a Schedule H drug under the Drugs and Cosmetics Act. It is included in the National List of Essential Medicines (NLEM) of India. As an injectable antibiotic, it is typically administered in hospital or clinic settings under medical supervision. The CDSCO mandates that its sale requires a valid prescription.
Frequently Asked Questions
Why should ceftriaxone never be mixed with calcium-containing solutions?
Ceftriaxone forms insoluble ceftriaxone-calcium precipitates that can deposit in the lungs and kidneys. This is especially dangerous in neonates. Never co-infuse ceftriaxone with Ringer lactate or calcium gluconate through the same IV line.
What is the standard adult dose of ceftriaxone in India?
The standard dose is 1-2 g IV or IM once daily. For meningitis, the dose is 2 g every 12 hours. For uncomplicated gonorrhoea, a single 250 mg IM dose is used.
Is ceftriaxone safe in neonates?
It should be used with caution in neonates, especially premature infants. It displaces bilirubin from albumin and can worsen neonatal jaundice. It is contraindicated in hyperbilirubinaemic neonates and must never be co-administered with calcium in this age group.
What are the common Indian brands of ceftriaxone?
Common brands include Monocef (Aristo), Ceftriaxone Injection IP by multiple manufacturers, Oframax (Ranbaxy/Sun), Monotax (Zydus), and Xone (Alkem).
Continue reading
Prescribing GuidesMetformin Prescribing Guide for Indian Clinical Practice
Evidence-based metformin prescribing for Indian clinicians covering dosing, brands, interactions, monitoring and NEET PG high-yield points.
Prescribing GuidesAmoxicillin Prescribing Guide for Indian Clinical Practice
Comprehensive amoxicillin prescribing reference for Indian doctors covering dosing, brands, resistance patterns and NEET PG high-yield pharmacology.
Prescribing GuidesParacetamol (Acetaminophen) Prescribing Guide for Indian Clinical Practice
Essential paracetamol prescribing guide for Indian clinicians covering hepatotoxicity thresholds, dosing, overdose management and NEET PG points.
Continue with Prescribing Guides
Apply what you have read with clinical prescribing MCQs that test real decision-making: drug choice, dose selection, interactions and monitoring.
Try prescribing questionsBrowse all prescribing guides

